Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-103689
Filing Date
2025-10-29
Accepted
2025-10-29 15:11:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 15548
  Complete submission text file 0001104659-25-103689.txt   17563
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Subject) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91725 | Film No.: 251429593
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE MARITIME PLAZA SUITE 2250 SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLAZA SUITE 2250 SAN FRANCISCO CA 94111 650-387-5779
Bering Partners II GP, L.L.C. (Filed by) CIK: 0001811744 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G